News

HealtNewest updates you on health,nutrition, lifestyle, fitness, diet, cancer, medicine, disease, wound care, beauty products, and other healthy living topics.

The 24-hour news cycle is just as important to medicine as it is to politics, finance, or sports. At MedPage Today, new information is posted daily, but keeping up can be a challenge. As an aid for our readers, here is a 10-question quiz based on the news of the week. Topics include adverse events
0 Comments
The survival rate following a sports-related cardiac arrest (SrSCA) almost tripled over a recent 12-year period, due in large part to increased bystander use of automated external defibrillators (AEDs) and cardiopulmonary resuscitation (CPR), results of a new study from France suggest. Lead author Nicole Karam, MD, PhD, associate professor in interventional cardiology, University of Paris, credits
0 Comments
The US Food and Drug Administration (FDA) today approved risankizumab-rzaa (Skyrizi) for a second indication — treating adults with active psoriatic arthritis (PsA) — making it the second anti-interleukin 23 monoclonal antibody available to treat PsA, according to an announcement from manufacturer AbbVie. The agency previously approved risankizumab in April 2019 for adults with moderate-to-severe
0 Comments
Black patients were more than twice as likely to have their patient behavior and history characterized in negative terms compared to white patients, data from electronic health records (EHRs) revealed. This higher likelihood of having a negative descriptor in their EHRs — with terms such as “resistant,” “noncompliant,” or “agitated” — showed up even after
0 Comments
The heart has played a central role in COVID-19 since the beginning. Cardiovascular conditions are among the highest risk factors for hospitalization. A significant number of patients hospitalized with SARS-CoV-2 infections have signs of heart damage, and many recover from infection with lasting cardiovascular injury.   It’s not surprising that debates over COVID-19 vaccines frequently
0 Comments
When the coronavirus pandemic was first declared, Spaniards were ordered to stay home for more than three months. For weeks, they were not allowed outside even for exercise. Children were banned from playgrounds, and the economy virtually stopped. But officials credited the draconian measures with preventing a full collapse of the health system. Lives were
0 Comments
Direct oral anticoagulants (DOACs) — the standard of care for treating venous thrombosis in noncancer patients — should also be the go-to for treating cancer-associated thrombosis (CAT), except in patients with a high risk of bleeding, a new analysis suggests. “Our meta-analysis finds that cancer patients who experience acute venous thrombosis events (VTEs) and [who]
0 Comments
Protection against the previously-dominant Delta variant was highest among people who were both vaccinated and had survived a previous COVID-19 infection, according to a report published Wednesday by the U.S. Centers for Disease Control and Prevention (CDC). The report also found those who had previously been infected with COVID-19 were better protected against the Delta variant
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Two years into the COVID-19 pandemic, the United States is still breaking records for hospital overcrowding and new cases. The US is logging nearly 800,000 cases a day, hospitals are starting to fray, and deaths in the US have topped 850,000. Schools
0 Comments
Following the emergence of the Delta variant, individuals who had a prior COVID-19 infection with or without vaccination had lower case rates than those who were vaccinated alone, data from California and New York found. “Infection-derived protection was higher after the Delta variant became predominant, a time when vaccine-induced immunity for many persons declined because
0 Comments
Patients with metastatic HER2-mutant non–small cell lung cancer (NSCLC) who received prior treatment may benefit from the antibody-drug conjugate trastuzumab deruxtecan (Enhertu), a new phase 2 trial suggests. The research, published today in The New England Journal of Medicine, revealed durable anticancer activity and encouraging survival outcomes in this patient population, reporting a median progression-free
0 Comments
Inside a busy intensive care unit in Toronto’s east end, Dr. Martin Betts often sees patients grappling with a double diagnosis: a serious health issue coupled with — or caused by — COVID-19. As chief of critical care for the Scarborough Health Network, Betts has treated several patients with diabetic ketoacidosis, a build-up of acids in
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The study covered in this summary was published in medRxiv.org as a preprint and has not yet been peer-reviewed. Key Takeaways Medication prescribing and dispensing in the United Kingdom were hampered during the COVID-19 pandemic and have not recovered to prepandemic
0 Comments
Specially designed spectacles can slow the progression of myopia, even during the lockdowns mandated by the COVID-19 pandemic, researchers say. Myopia progressed 46% more slowly in children prescribed defocus incorporated multiple segments (DIMS) lenses than in children prescribed standard prescription spectacles during 12 months when the children attended school at a distance, said Henry Chan,
0 Comments
Doctors say an allegation out of Beijing that China’s first Omicron case may be linked to mail received from Toronto should be treated with deep skepticism. Chinese health authorities said earlier Monday that a case of Omicron in Beijing may have spread from a package received from Canada. They urged citizens to stop ordering parcels from abroad
0 Comments